By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Source BioScience said today that it will provide drugmaker AstraZeneca with a companion diagnostic testing service for lung cancer patients in the UK.

The service agreement with AstraZeneca will enable doctors at the National Health Service to identify which lung cancer patients have certain genetic mutations in their tumors that may make them sensitive to tyrosine kinase inhibitor therapies, which in turn may help guide doctors' treatment decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.